Urology Annals, published by Wolters Kluwer Medknow Publications, is a premier open-access journal dedicated to advancing the field of urology through high-quality research and clinical insights. Established in India in 2009, this journal serves as a vital platform for communication among urologists, researchers, and medical professionals, aiming to enhance understanding and innovation in urological sciences. With an ISSN of 0974-7796 and an E-ISSN of 0974-7834, the journal offers unrestricted access to its content, fostering knowledge dissemination and collaboration across the global medical community. Currently ranked in the Q3 category within urology and holding a Scopus rank of #79/120, Urology Annals showcases significant contributions that align with its mission to publish original research, reviews, and case reports that address contemporary challenges in urology. The journal's ongoing commitment to remaining a leading resource in the field is reflected through its convergence of years from 2010 to 2024, ensuring that it stays at the forefront of the latest urological advancements.

European Urology Focus is a premier journal published by Elsevier, dedicated to advancing the field of urology. With its inception dating back to 2015 and a convergence period extending through 2024, this journal has rapidly established itself as a leading platform within the medical community, boasting an impressive Scopus ranking of #5 out of 120 in Urology, placing it in the 96th percentile. The journal is recognized for its impactful contributions to urological research, and it is classified in the prestigious Q1 category for Urology in 2023. Based in the Netherlands, European Urology Focus prioritizes innovative research, reviews, and clinical observations, catering not only to seasoned professionals but also to emerging scholars and practitioners in the field. While traditionally a subscription-based journal, it offers flexible access options tailored for its diverse readership. With a commitment to enhancing knowledge and improving patient outcomes in urological health, European Urology Focus stands as a vital resource for those engaged in this essential area of medicine.

Translational Andrology and Urology is a premier journal published by AME Publishing Company, dedicated to advancing research in the fields of reproductive medicine and urology. Established in 2012 and gaining prominence with its Q2 rankings in both the reproductive medicine and urology categories as of 2023, this journal serves as a vital platform for disseminating groundbreaking studies and clinical advancements. With an ISSN of 2223-4683 and an E-ISSN of 2223-4691, it is indexed in Scopus, standing at a distinguished rank of #40/120 in Urology and #33/90 in Reproductive Medicine. Located in Hong Kong, the journal reflects a commitment to open access and international collaboration, providing researchers, professionals, and students with critical insights and updates in these dynamic fields. As a leading resource, Translational Andrology and Urology invites contributions that explore innovative approaches that can enhance patient care and clinical practices.

CUAJ - Canadian Urological Association Journal is a premier, peer-reviewed journal dedicated to advancing the field of urology, published by the Canadian Urological Association. With its ISSN 1911-6470 and E-ISSN 1920-1214, the journal serves as a vital platform for disseminating high-quality research and clinical insights relevant to urology and oncology. Located in Canada, CUAJ is committed to publishing original research, reviews, and case studies that contribute to the scientific community's understanding of urological diseases and treatments. As of 2023, CUAJ holds a notable ranking of Q2 in Urology and Q3 in Oncology, reflecting its rigorous editorial standards and impactful contributions to the field, particularly acknowledged by its Scopus ranking as #61 in the Medicine and Urology category. Although primarily not an open-access journal, it aims to foster scholarly communication that empowers researchers, healthcare professionals, and students. With a rich history from its inception in 2007, CUAJ continues to play an integral role in shaping urological education and practice, making it an essential read for anyone involved in this dynamic field.

Current Urology, published by Lippincott Williams & Wilkins, is a leading journal dedicated to advancing the fields of urology, oncology, and reproductive medicine. With an ISSN of 1661-7649 and E-ISSN of 1661-7657, this journal has established itself as a valuable resource for researchers, practitioners, and students alike, providing peer-reviewed articles that contribute to the ongoing discourse and development of these critical specialties. Operating out of the United States, Current Urology ranks in the third quartile for oncology, reproductive medicine, and urology, reflecting its importance in the medical community. The journal’s focus on innovative research and clinical practice allows it to bridge gaps between theoretical understanding and practical application, enhancing patient care and outcomes. Although currently not an open-access journal, it offers a wealth of insights and findings that underpin contemporary urological practices and research. In an evolving medical landscape, Current Urology remains an essential platform for disseminating knowledge and fostering collaboration among experts in the field.

European Urology Open Science is a premier open-access journal dedicated to advancing the field of urology through publishing high-quality, peer-reviewed research. Published by ELSEVIER in the Netherlands, this journal is recognized for its significant contribution to the medical community, boasting an impressive Q1 ranking in Urology for 2023, indicative of its influence and the quality of research it disseminates. With a focus on innovative studies and interdisciplinary approaches, the European Urology Open Science plays a pivotal role in fostering knowledge exchange and promoting clinical best practices. Researchers, professionals, and students alike benefit from its accessible research format, facilitating a broader dissemination of urological advancements. This journal embraces the Open Access model, ensuring that pioneering findings are readily available to the global scientific community, further enhancing collaboration and knowledge sharing within the field.

Welcome to the Scandinavian Journal of Urology, a dynamic platform dedicated to advancing the fields of urology and nephrology. Published by Medical Journal Sweden AB and located in the United Kingdom, this esteemed journal features open access options that enhance the accessibility of cutting-edge research to a global audience. With an impressive impact factor and a respectable position in Scopus rankings—#55/120 in Urology and #45/81 in Nephrology—the journal occupies a vital niche for researchers, clinicians, and students eager to share and engage with pioneering studies from 2013 to 2024. As part of the Q2 quartile in both urology and nephrology categories, the Scandinavian Journal of Urology plays a crucial role in informing and shaping contemporary clinical practices and research directions. Join us in exploring the latest developments and evidence-based findings in these essential areas of medical science.

International Brazilian Journal of Urology, published by the Brazilian Society of Urology, is a distinguished open-access journal that has been contributing to the field of urology since 2003. This journal plays a vital role in disseminating high-quality research and advancements in various aspects of urological science and medicine, targeting an international audience of researchers, practitioners, and students. With an impressive ranking in the 2023 Scopus metrics, securing Q2 status in both Medicine (Miscellaneous) and Urology, it stands as a significant resource for emerging trends and discoveries in these areas. The journal’s commitment to accessibility, with open access since its inception, ensures that valuable findings are readily available to the global medical community. Situated in Rio de Janeiro, Brazil, the International Brazilian Journal of Urology not only enhances academic discourse but also fosters collaboration across borders and specialties, making it a pivotal platform for advancing urological research.

Urological Science, published by Lippincott Williams & Wilkins, is a prominent open-access journal that has been a vital resource for the Urology field since its establishment in 2010. With a focus on innovative research and advancements in urological science, the journal aims to disseminate significant findings and encourage dialogue among physicians, researchers, and healthcare professionals worldwide. The journal has achieved a commendable Q3 rank within its category according to the latest quartiles released in 2023 and holds a Scopus rank of #80 out of 120 in the Medicine Urology field, placing it in the 33rd percentile. By providing an open-access platform, Urological Science ensures that vital research is easily accessible to a global audience, supporting the ongoing advancements in urological healthcare and education. As the landscape of urology evolves, this journal remains an essential vehicle for sharing knowledge and improving patient outcomes, making it an invaluable resource for anyone invested in the future of urological science.

Canadian Journal of Urology, published by CANADIAN J UROLOGY, is a prominent peer-reviewed journal dedicated to advancing the field of urology and its allied disciplines. Established in 2000, this journal has consistently aimed to provide a platform for comprehensive research, clinical studies, and innovative practices in urology and general medicine, ensuring that professionals remain at the forefront of medical advancements. With a reputation reflected in its 2023 Scopus ranking of Q3 in both Urology and Medicine (miscellaneous), the journal serves as an essential resource for researchers and practitioners seeking to enhance their knowledge and application of urological sciences. Although it is not an Open Access journal, its impactful findings contribute significantly to the medical community in Canada and beyond, promoting evidence-based practices and contributing to better patient outcomes. As the journal converges into 2024, it continues to welcome high-quality submissions that explore critical challenges and advancements in urology.